ALIMERA SCIENCES INC

ALPHARETTA, GA How do I update this listing?

Alimera Sciences is based out of Alpharetta. Alimera Sciences Inc. operates as a biopharmaceutical company. The Company researches, develops, and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the back of the eye and retina.Whalewisdom has at least 2 13G filings, and 156 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2021-04-27. The notice included securities offered of Equity

Create Alert

Contact Info

alimera sciences inc
6120 WINDWARD PARKWAY
ALPHARETTA GA    30005

Business Phone: 678-990-5740
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2021-04-27 D PHARMACEUTICALS Equity 10,000,000 10,000,000 0
2012-10-05 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 40,000,000 40,000,000 0
2011-05-25 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security 332,486 332,486 0
2009-09-04 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 5,000,000 5,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANDERS HOVE subscription required
    DIRECTOR
BRIAN HALAK subscription required
    DIRECTOR
BRYCE YOUNGREN subscription required
    DIRECTOR
C. DANIEL MYERS subscription required
    EXECUTIVE OFFICER DIRECTOR
CALVIN ROBERTS subscription required
    DIRECTOR
CHARLES DANIEL MYERS subscription required
    EXECUTIVE OFFICER DIRECTOR
DAVID HOLLAND subscription required
    EXECUTIVE OFFICER
GARHENG KONG subscription required
    DIRECTOR
GLEN BRADLEY subscription required
    DIRECTOR
J. PHILIP JONES subscription required
    EXECUTIVE OFFICER
JAMES R. LARGENT subscription required
    DIRECTOR
JOHN SNISARENKO subscription required
    DIRECTOR
KENNETH GREEN subscription required
    EXECUTIVE OFFICER
MARK BROOKS subscription required
    DIRECTOR
MARY T. SZELA subscription required
    DIRECTOR
PETER J. PIZZO subscription required
    DIRECTOR
PHIL TRACY subscription required
    DIRECTOR
PHILIP ASHMAN subscription required
    EXECUTIVE OFFICER
PHILIP TRACY subscription required
    DIRECTOR
RICHARD EISWIRTH subscription required
    EXECUTIVE OFFICER
SUSAN CABALLA subscription required
    EXECUTIVE OFFICER

Elevate your investments